UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia

Antioxidants, 2017-04, Vol.6 (2), p.27

2017

Link zum Volltext

Verfügbarkeit prüfen

Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling

The Journal of biological chemistry, 2012-02, Vol.287 (6), p.3610-3616

2012

Link zum Volltext

Verfügbarkeit prüfen

PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species

Molecular cancer therapeutics, 2016-07, Vol.15 (7), p.1637-1647

2016

Link zum Volltext

Verfügbarkeit prüfen

Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53

Cancer research (Chicago, Ill.), 2015-09, Vol.75 (18), p.3842-3852

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy

Cells (Basel, Switzerland), 2022-11, Vol.11 (22), p.3700

2022

Link zum Volltext

Verfügbarkeit prüfen

Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins

Frontiers in oncology, 2023-01, Vol.12, p.1083150-1083150

2023

Link zum Volltext

Verfügbarkeit prüfen

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28

Cells (Basel, Switzerland), 2022-03, Vol.11 (6), p.1006

2022

Link zum Volltext

Verfügbarkeit prüfen

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

Clinical cancer research, 2007-09, Vol.13 (17), p.5183-5194

2007

Link zum Volltext

Verfügbarkeit prüfen

PIM kinase (and Akt) biology and signaling in tumors

Pharmacology & therapeutics (Oxford), 2015-07, Vol.151, p.41-49

2015

Link zum Volltext

Verfügbarkeit prüfen

Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α

Oncotarget, 2022, Vol.13 (1), p.454-455

Warfel, Noel A

2022

Link zum Volltext

Verfügbarkeit prüfen

p21WAF1 and tumourigenesis: 20 years after

Current opinion in oncology, 2013-01, Vol.25 (1), p.52-58

2013

Link zum Volltext

Verfügbarkeit prüfen

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors

Diagnostics (Basel), 2022-03, Vol.12 (3), p.676

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Molecular cancer therapeutics, 2021-01, Vol.20 (1), p.3-10

2021

Link zum Volltext

Verfügbarkeit prüfen

Optimized in vitro three-dimensional invasion assay for quantifying a wide range of cancer cell invasive behavior

STAR protocols, 2022-09, Vol.3 (3), p.101516-101516, Article 101516

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

Cell cycle (Georgetown, Tex.), 2017-07, Vol.16 (13), p.1241-1242

Warfel, Noel A.

2017

Link zum Volltext

Verfügbarkeit prüfen

PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer

Oncogene, 2020-03, Vol.39 (12), p.2597-2611

2020

Link zum Volltext

Verfügbarkeit prüfen

CTGF-mediated autophagy-senescence transition in tumor stroma promotes anabolic tumor growth and metastasis

Cell cycle (Georgetown, Tex.), 2012-07, Vol.11 (14), p.2592-2593

2012

Link zum Volltext

Verfügbarkeit prüfen

CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth

Cell cycle (Georgetown, Tex.), 2013-12, Vol.12 (23), p.3689-3701

2013

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents

Clinical cancer research, 2018-01, Vol.24 (1), p.169-180

2018

Link zum Volltext

Verfügbarkeit prüfen

PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer

Oncogene, 2024-02, Vol.43 (6), p.406-419

2024

Link zum Volltext

Verfügbarkeit prüfen

Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors

Oncogene, 2021-08, Vol.40 (32), p.5142-5152

2021

Link zum Volltext

Verfügbarkeit prüfen

PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer

Cell chemical biology, 2024-02, Vol.31 (2), p.326-337.e11

2024

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2710-2721

2018

Link zum Volltext

Verfügbarkeit prüfen

PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion

The Journal of cell biology, 2023-06, Vol.222 (6), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2

The Journal of biological chemistry, 2011-11, Vol.286 (45), p.39122-39129

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(60)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Humans
(26)
Animals
(20)
Mice
(15)
Oncology
(14)
Cell Line, Tumor
(13)
Biochemistry & Molecular Biology
(11)
Cell Biology
(11)
Hypoxia
(11)
Male
(11)
Cancer
(9)
Prostate Cancer
(9)
Tumors
(9)
Apoptosis
(8)
Angiogenesis
(7)
Phosphorylation
(7)
Prostatic Neoplasms - Pathology
(7)
Proto-Oncogene Proteins C-Akt - Metabolism
(7)
Signal Transduction
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia

Pleckstrin Homology Domain Leucine-rich Repeat Protein Phosphatase (PHLPP): A New Player in Cell Signaling

PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species

Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy

Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins

Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28

Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo

PIM kinase (and Akt) biology and signaling in tumors

Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α

p21WAF1 and tumourigenesis: 20 years after

GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors

Targeting PIM Kinases to Overcome Therapeutic Resistance in Cancer

Optimized in vitro three-dimensional invasion assay for quantifying a wide range of cancer cell invasive behavior

Targeting CDK4/6 to oppose hypoxia-mediated therapeutic resistance

PIM kinases alter mitochondrial dynamics and chemosensitivity in lung cancer

CTGF-mediated autophagy-senescence transition in tumor stroma promotes anabolic tumor growth and metastasis

CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth

Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents

PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer

Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors

PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer

Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase

PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion

Disruption of the Interface between the Pleckstrin Homology (PH) and Kinase Domains of Akt Protein Is Sufficient for Hydrophobic Motif Site Phosphorylation in the Absence of mTORC2

Suchergebnisse filtern